Influenza Treatment Market by Product Type and Distribution Channel, Global Opportunity Analysis and Industry Forecast, 2019–2026

Influenza Treatment Market by Product Type and Distribution Channel, Global Opportunity Analysis and Industry Forecast, 2019–2026

  • March 2020 •
  • 194 pages •
  • Report ID: 5897587 •
  • Format: PDF
Influenza Treatment Market by Product Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, and Others) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Others), Global Opportunity Analysis and Industry Forecast, 2019–2026

The global protein expression market was valued at $2,121 million in 2018 and is projected to reach $4,611 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.
Protein expression refers to a biotechnological process of generating specific protein, typically attained by manipulation of gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled expression and isolation of recombinant proteins in large scale. One of the major achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to completely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellularly operating enzymes though therapeutic protein. The first expression platform established was prokaryotic system through Escherichia coli. This was followed by development of other expression systems including yeast, algae, insect, and mammalian.
The factors that boost the growth of the protein expression market include surge in geriatric population and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market. Conversely, emergence of microfluids, along with growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.
The global protein expression market is segmented on the basis of product, application, and region. On the basis of product, it is divided into reagents, expression vectors, competent cells, instruments, and services. By application, it is divided into therapeutic, industrial, and research. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
•This report entails a detailed quantitative analysis along with the current protein expression market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment
•The market forecast is studied from 2019 to 2026
•The market size and estimations are based on a comprehensive analysis of key developments in the industry
•A qualitative analysis based on innovative products facilitates strategic business planning
•The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Product
•Reagents
•Expression vectors
•Competent cells
•Instruments
•Services

By Application
•Therapeutic
•Industrial
•Research

By Region
•North America
oU.S.
oCanada
oMexico
•Europe
oGermany
oFrance
oUK
oItaly
oSpain
oRest of Europe
•Asia-Pacific
oJapan
oChina
oIndia
oRest of Asia-Pacific
•LAMEA
oLatin America
oMiddle-East
oRest of LAMEA